Korro Bio (KRRO) Market Capitalization (2019 - 2026)

Korro Bio (KRRO) has reported Market Capitalization for 8 consecutive years, with $193.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 65.25% year-over-year to $193.8 million; the trailing twelve-month figure through Jun 2026 stood at $193.8 million (up 65.25% YoY), and the FY2025 full-year result was $75.4 million, down 78.87% from the prior year.
• Market Capitalization improved to $193.8 million in Q2 2026 per KRRO's latest filing, from $131.3 million in the prior quarter.
• Across five years, Market Capitalization topped out at $722.0 million in Q1 2024 and bottomed at $4.8 million in Q2 2023.
• Historically, Market Capitalization has averaged $176.3 million across 5 years, with a median of $96.4 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization tumbled 90.88% in 2023, then jumped 10473.22% in 2024.
• Over 5 years, Market Capitalization stood at $49.1 million in 2022, then surged by 49.22% to $73.3 million in 2023, then soared by 387.03% to $357.0 million in 2024, then plunged by 78.87% to $75.4 million in 2025, then jumped by 156.95% to $193.8 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $193.8 million, $131.3 million, and $75.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.